✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹158 Cr.
P/E
11.64
About
Tyche Industries Ltd, initially a software company, diversified into the production of fine chemicals and is a leading manufacturer of API's, Intermediates, Nutraceuticals, Fine and Specialty Chemical… Read more
Tyche Industries Ltd, initially a software company, diversified into the production of fine ch… Read more
Low
129
52W Range
High
229
  • Tyche Inds
  • Bal Pharma
  • Smruthi Organics

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Advertisement Spend as a % of Total Sales (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Tyche Industries Ltd. Business

    Tyche Industries Ltd started as a software company and later expanded into manufacturing fine chemicals. They specialize in API's, Intermediates, Nutraceuticals, Fine and Specialty Chemicals through Custom Synthesis/Contract/Toll Manufacturing and Research & Development.

    Tyche Inds major competitors are Bal Pharma, Smruthi Organics, Mangalam Drugs&Org., Lasa Supergenerics, Everest Organics, SMS Lifesciences, Nectar Lifesciences.
    Market Cap of Tyche Inds is ₹158 Crs.
    While the median market cap of its peers are ₹178 Crs.

    Tyche Inds seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Jun
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material